Michael Roden

Michael Roden is Chair (W3-Professor) of Internal Medicine, Endocrinology and Metabolic Diseases at Heinrich-Heine University Düsseldorf. He also serves as Deputy Head of the Department of Conservative Medicine, Director of the Division of Endocrinology & Diabetology at University Hospital Düsseldorf, CEO of the German Diabetes Center (DDZ), and member of the Speakers' Assembly of the German Centers of Health Research (DZD).

• Chair of Internal Medicine (W3), Heinrich-Heine University Düsseldorf, Germany
• Director, Division of Endocrinology & Diabetology, University Hospital Düsseldorf
• CEO, German Diabetes Center (DDZ)
• Member, German National Academy of Sciences (Leopoldina)

Research Interests: Michael Roden's work focuses on mechanisms of insulin resistance, mitochondrial dysfunction, and metabolic inflammation in diabetes and obesity. His studies investigate ectopic fat storage, noninvasive metabolic flux tracing, and precision medicine approaches for diabetes management, alongside carbohydrate, lipid, and amino acid metabolism in clinical-experimental settings.

Scientific Awards:

• Paul-Langerhans Medal (2017)
• G. B. Morgagni Prize (2018)
• Oskar-Minkowski Prize (2006)
• World-India Diabetes Foundation Global Oration (2014)
• Werner-Creutzfeldt Prize (2021)
• Distinguished honorary doctorates from Athens and Belgrade

Grants & Leadership: His research is funded by the German Federal Ministry of Health, European Research Council, and German Research Foundation. He co-directed the creation of the CARDDIAB research building at Heinrich-Heine University and chairs international guidelines committees for NAFLD and diabetes management.